CAS: 473921-12-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile REF: AN-AG00DB6KCAS: 473921-12-9 | 98% | 106.00 €~553.00 € | Tue 04 Jun 24 |
 | Lersivirine REF: TM-T7700CAS: 473921-12-9 | 99.26% | 64.00 €~738.00 € | Tue 11 Jun 24 |
 | Lersivirine REF: 3D-FL65058CAS: 473921-12-9 | Min. 95% | 246.00 €~999.00 € | Thu 13 Jun 24 |
![3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile](https://static.cymitquimica.com/products/AN/thumb/AG00DB6K.jpg)
3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile
CAS:473921-12-9
Formula:
C17H18N4O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
310.3504
Ref: AN-AG00DB6K
| 25mg | 147.00 € | |
| 50mg | 246.00 € | |
| 100mg | 553.00 € |
Estimated delivery in United States, on Tuesday 4 Jun 2024
Lersivirine
CAS:473921-12-9
Lersivirine (UK-453061)(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV …
Formula:
C17H18N4O2
Purity:
99.26%
Color and Shape:
Solid
Molecular weight:
310.35
Ref: TM-T7700
| 1mg | 64.00 € | |
| 2mg | 90.00 € | |
| 5mg | 116.00 € | |
| 10mg | 185.00 € | |
| 25mg | 352.00 € | |
| 50mg | 525.00 € | |
| 100mg | 738.00 € | |
| 1ml*10 (DMSO) | 127.00 € |
Estimated delivery in United States, on Tuesday 11 Jun 2024
Lersivirine
CAS:473921-12-9
Anti-viral; non-nucleoside reverse transcriptase inhibitor
Formula:
C17H18N4O2
Purity:
Min. 95%
Color and Shape:
Solid
Molecular weight:
310.14298
Ref: 3D-FL65058
| 5mg | 246.00 € | |
| 10mg | 389.00 € | |
| 25mg | 716.00 € | |
| 50mg | 999.00 € |
Estimated delivery in United States, on Thursday 13 Jun 2024
